Library
innospark.vcCrawled Oct 21, 2026
Product
6 pages- Fundraising/platform/fundraising
- Overview/platform/overview
Innospark resources, documents and vendors.
- People & Operations/platform/people-operations
- Portfolio/portfolio
Blog
6 pages- 10 Predictions for 2025/10-predictions-for-2025
2025 is now in full swing, and the AI landscape continues to evolve at an accelerating pace, with both anticipated and unexpected developments shaping the
- AI in Healthcare/ai-in-healthcare-copy
By Venkat Srinivasan (Managing Director), Mark Legare (Principal), and Yuri Ahuja (TIR)
- Why We Invested - Copernic Catalysts/copernic-why-we-invested
- Why We Invested - Juniper Genomics/why-we-invested-juniper-genomics
Press
6 pages- Following pivot to enterprise SaaS model, Haloo closes $4.7 million CAD/following-pivot-to-enterprise-saas-model-haloo-closes-4-7-million-cad
- Fourier Health Raises $8.4M for AI Medical Summarization/fourier-health-raises-8-4m-for-ai-medical-summarization
Round led by Yosemite, with participation from NextGen Venture Partners, Innospark Ventures, Tau Ventures, and others
- Marigold Health raises $11M for peer-based addiction support/marigold-health-raises-11m-for-peer-based-addiction-support
- Newsroom/newsroom
Careers & Hiring
1 page- Careers/careers
Team
6 pages- Jeff Knox/team/jeff-knox
- Max Krause/team/max-krause
- Team/team
Innospark Technologists in Residence are experts with advanced degrees who assess AI solutions, advise portfolio companies, and link Innospark to leading AI research and applications.
- Welcome Marjan Majid!/welcome-marjan-majid
About
1 page- Strategy/strategy
Innospark Ventures combines startup-building, operational, and investment experience to support success in entrepreneurship.
Contact
1 page- Contact/contact
Innospark Ventures invites companies to share details about their business, funding, and relevant materials for review.
Homepage
1 page- Homepage/
Innospark Ventures invests in founders addressing complex challenges through Artificial Intelligence.
Coverage
6 items- Why We Invested - Juniper Genomicsinnospark.vc/why-we-invested-juniper-genomics/
Juniper Genomics develops embryo selection tools for in vitro fertilization (IVF). Traditional IVF methods use visual inspection and chromosome screening, which fail to predict live birth outcomes for over half of transferred embryos. The company aims to provide deeper biological insights to improve embryo viability assessment.
Oct 2025Innospark VenturesNews article
- Why We Invested - Kreverainnospark.vc/why-we-invested-krevera/
Krevera applies AI-driven computer vision to modernize manufacturing processes. The company develops tools that enhance operational efficiency and quality control in industrial settings. Innospark VC backs Krevera to accelerate its mission of integrating AI into factory automation.
Jul 2025Innospark VenturesNews article
- Why We Invested - Copernic Catalystsinnospark.vc/copernic-why-we-invested/
Copernic Catalysts develops advanced catalysts to modernize ammonia production, a century-old process requiring extreme heat and pressure. The company targets both fertilizer manufacturing and renewable energy storage, where ammonia could transport clean energy globally. Innospark VC highlights the potential to disrupt an 180-million-tonne-per-year industry with more efficient, sustainable methods.
Mar 2025Innospark VenturesNews article
- Why We Invested - Phaseshift Technologiesinnospark.vc/why-we-invested-phaseshift-technologies/
Innospark VC backs Phaseshift Technologies to advance its quantum computing hardware innovations. The firm highlights the startup’s potential to disrupt traditional computing paradigms through novel approaches in qubit control and coherence. Phaseshift’s technology targets enterprise and research applications where high-performance quantum systems are increasingly critical.
Dec 2024Innospark VenturesNews article
